Skip to main content
Advertisement
Advertisement

EVH

EVH logo

Evolent Health, Inc Class A Common Stock

3.69
USD
Sponsored
+0.02
+0.54%
Sep 18, 15:59 UTC -4
Closed
exchange

After-Market

3.70

+0.01
+0.27%

EVH Earnings Reports

Positive Surprise Ratio

EVH beat 33 of 43 last estimates.

77%

Next Report

Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$733.04M
/
$0.05
Implied change from Q2 26 (Revenue/ EPS)
+12.34%
/
+150.00%
Implied change from Q3 25 (Revenue/ EPS)
+52.87%
/
--

Evolent Health, Inc Class A Common Stock earnings per share and revenue

On Aug 06, 2026, EVH reported earnings of 0.02 USD per share (EPS) for Q2 26, beating the estimate of -0.02 USD, resulting in a 183.68% surprise. Revenue reached 652.52 million, compared to an expected 603.98 million, with a 8.04% difference. The market reacted with a +16.56% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 13 analysts forecast an EPS of 0.05 USD, with revenue projected to reach 733.04 million USD, implying an increase of 150.00% EPS, and increase of 12.34% in Revenue from the last quarter.
FAQ
For Q2 2026, Evolent Health, Inc Class A Common Stock reported EPS of $0.02, beating estimates by 183.68%, and revenue of $652.52M, 8.04% above expectations.
The stock price moved up 16.56%, changed from $3.08 before the earnings release to $3.59 the day after.
The next earning report is scheduled for Nov 04, 2026.
Based on 13 analysts, Evolent Health, Inc Class A Common Stock is expected to report EPS of $0.05 and revenue of $733.04M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement